For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Viking Therapeutics Inc (NASDAQ: VKTX) closed at $27.01 in the last session, down -8.41% from day before closing price of $29.49. In other words, the price has decreased by -$8.41 from its previous closing price. On the day, 3.95 million shares were traded.
Ratios:
We take a closer look at VKTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 44.25 and its Current Ratio is at 44.25. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 29, 2025, initiated with a Overweight rating and assigned the stock a target price of $104.
On April 08, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $30.
On February 13, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $102.Scotiabank initiated its Sector Outperform rating on February 13, 2025, with a $102 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 31 ’25 when Rouan Sarah Kathryn bought 1,240 shares for $24.15 per share. The transaction valued at 29,943 led to the insider holds 1,240 shares of the business.
Lian Brian sold 194,490 shares of VKTX for $8,313,601 on Jan 06 ’25. The President & CEO now owns 2,366,570 shares after completing the transaction at $42.75 per share. On Jan 06 ’25, another insider, Mancini Marianna, who serves as the Chief Operating Officer of the company, sold 54,215 shares for $42.75 each. As a result, the insider received 2,317,599 and left with 374,134 shares of the company.
Stock Price History:
Over the past 52 weeks, VKTX has reached a high of $81.86, while it has fallen to a 52-week low of $18.92. The 50-Day Moving Average of the stock is 1.80%, while the 200-Day Moving Average is calculated to be -41.40%.
Shares Statistics:
A total of 112.29M shares are outstanding, with a floating share count of 108.99M. Insiders hold about 2.96% of the company’s shares, while institutions hold 72.85% stake in the company.
Earnings Estimates
The stock of Viking Therapeutics Inc (VKTX) is currently drawing attention from 16.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.48, with high estimates of -$0.37 and low estimates of -$0.72.
Analysts are recommending an EPS of between -$1.48 and -$2.57 for the fiscal current year, implying an average EPS of -$1.84. EPS for the following year is -$2.49, with 15.0 analysts recommending between -$1.77 and -$4.01.
